These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26695227)

  • 1. A sandwich immunoassay for detection of Aβ(1-42) based on quantum dots.
    Pi J; Long Y; Huang N; Cheng Y; Zheng H
    Talanta; 2016; 146():10-5. PubMed ID: 26695227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum dots-based sandwich immunoassay for sensitive detection of Alzheimer's disease-related Aβ
    Tang M; Pi J; Long Y; Huang N; Cheng Y; Zheng H
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Aug; 201():82-87. PubMed ID: 29734108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive electrochemical immunoassay for detection of β-amyloid (1-42) and total β-amyloid peptides using p-aminophenol redox cycling.
    Liu L; He Q; Zhao F; Xia N; Liu H; Li S; Liu R; Zhang H
    Biosens Bioelectron; 2014 Jan; 51():208-12. PubMed ID: 23962708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
    Xia N; Zhou B; Huang N; Jiang M; Zhang J; Liu L
    Biosens Bioelectron; 2016 Nov; 85():625-632. PubMed ID: 27240009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.
    Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M
    J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrochemical detection of β-amyloid peptides on electrode covered with N-terminus-specific antibody based on electrocatalytic O2 reduction by Aβ(1-16)-heme-modified gold nanoparticles.
    Liu L; Zhao F; Ma F; Zhang L; Yang S; Xia N
    Biosens Bioelectron; 2013 Nov; 49():231-5. PubMed ID: 23770394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene quantum dots for detecting monomeric amyloid peptides.
    Huang H; Li P; Zhang M; Yu Y; Huang Y; Gu H; Wang C; Yang Y
    Nanoscale; 2017 Apr; 9(16):5044-5048. PubMed ID: 28397888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemiluminescence immunosensor of "signal-off" for β-amyloid detection based on dual metal-organic frameworks.
    Dong X; Zhao G; Li X; Fang J; Miao J; Wei Q; Cao W
    Talanta; 2020 Feb; 208():120376. PubMed ID: 31816770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β
    Negahdary M; Heli H
    Mikrochim Acta; 2019 Nov; 186(12):766. PubMed ID: 31713687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.
    Nutu M; Zetterberg H; Londos E; Minthon L; Nägga K; Blennow K; Hansson O; Ohrfelt A
    Dement Geriatr Cogn Disord; 2013; 36(1-2):99-110. PubMed ID: 23860354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Technical Validation of an Immunoassay for the Detection of APP
    Klafki HW; Rieper P; Matzen A; Zampar S; Wirths O; Vogelgsang J; Osterloh D; Rohdenburg L; Oberstein TJ; Jahn O; Beyer I; Lachmann I; Knölker HJ; Wiltfang J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
    Jongbloed W; Bruggink KA; Kester MI; Visser PJ; Scheltens P; Blankenstein MA; Verbeek MM; Teunissen CE; Veerhuis R
    J Alzheimers Dis; 2015; 45(1):35-43. PubMed ID: 25547634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of β-amyloid oligomers.
    Zhou Y; Zhang H; Liu L; Li C; Chang Z; Zhu X; Ye B; Xu M
    Sci Rep; 2016 Oct; 6():35186. PubMed ID: 27725775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method of labeling amyloid β with quantum dots and ingestion of the labeled amyloid β by astrocytes.
    Zhang J; Jia X; Qing H; Xie HY
    Nanotechnology; 2013 Jan; 24(3):035101. PubMed ID: 23262662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation.
    Mai TD; Pereiro I; Hiraoui M; Viovy JL; Descroix S; Taverna M; Smadja C
    Analyst; 2015 Sep; 140(17):5891-900. PubMed ID: 26206107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graphene oxide-gold nanoparticle-aptamer complexed probe for detecting amyloid beta oligomer by ELISA-based immunoassay.
    Zhao J; Chang W; Liu L; Xing X; Zhang C; Meng H; Gopinath SCB; Lakshmipriya T; Chen Y; Liu Y
    J Immunol Methods; 2021 Feb; 489():112942. PubMed ID: 33333060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.